Corcept Therapeutics Inc
Change company Symbol lookup
Select an option...
CORT Corcept Therapeutics Inc
CVS CVS Health Corp
NVAX Novavax Inc
MRK Merck & Co Inc
HYT BlackRock Corporate High Yield Fund, Inc
FNMA Federal National Mortgage Association
CPKF Chesapeake Financial Shares Inc
AGNC Agnc Investment Corp
BYND Beyond Meat Inc
NDENF Central African Gold Inc
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The Company is developing mifepristone, a compound that modulates the effects of cortisol by acting as a competitive antagonist at the glucocorticoid receptor (GR). As of December 31, 2016, it had discovered three structurally distinct series of selective cortisol modulators, all of which share mifepristone's affinity for GR but, unlike mifepristone, do not bind to the progesterone receptor. It is conducting two clinical trials of its selective cortisol modulator, CORT125134. One trial is investigating CORT125134 as a treatment for patients with Cushing syndrome. The second trial is investigating the combination of CORT125134 and nab-paclitaxel (Celgene Corporation's Abraxane) to treat patients with solid-tumor cancers.

Closing Price
$17.70
Day's Change
-0.30 (-1.67%)
Bid
--
Ask
--
B/A Size
--
Day's High
18.33
Day's Low
17.46
Volume
(Average)
Volume:
580,115

10-day average volume:
576,703
580,115

U.S. stocks end with gains as Dow enjoys best week since August

4:09 pm ET October 9, 2020 (MarketWatch)
Print

U.S. stocks rose Friday to clinch weekly gains as investors monitored the prospects for another round of fiscal stimulus from Congress, with President Donald Trump, once again, saying he was open to a broader package. The S&P 500 rose 0.9% to 3,477.13. The Dow Jones Industrial Average advanced 161.39 points, or 0.6%, to 28,586.90, based on preliminary numbers. The Nasdaq Composite gained 1.4% to end at 11,579.94. For the week, the S&P 500 was up 3.8%, the Dow rose 3.3%, and the Nasdaq climbed 4.6%. The S&P 500 and Nasdaq enjoyed their best week since July, while the Dow had its biggest weekly gain since August. Investors also saw some corporate deal-making after The Wall Street Journal reporting that Advanced Micro Devices Inc. (AMD) was in talks to buy rival chip maker Xilinx Inc. (XLNX)

-Sunny Oh; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

October 09, 2020 16:09 ET (20:09 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.